Tag: Brittle bone disease
Mereo BioPharma begins BPS-804 mid-stage trial in osteogenesis imperfecta
British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that will evaluate its human monoclonal ... Read More